Not Medicare Enrolled

Dr. Rafael Beltran Durango, M.D.

Psychiatry · St Petersburg, FL
3637 4TH ST N, St Petersburg, FL 33704
7278942341
Registered in NPPES since 2006
NPI: 1093807075 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Beltran Durango from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beltran Durango? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Beltran Durango

Dr. Rafael Beltran Durango is a psychiatry specialist in St Petersburg, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Beltran Durango received a total of $12,561 from 39 pharmaceutical and/or device companies across 529 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Beltran Durango is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $12,561 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,561
Total received (2018-2024)
Avg $1,794/year across 7 years
Top 7% in FL for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
529
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,076
2023
$2,540
2022
$1,586
2021
$1,311
2020
$1,100
2019
$1,915
2018
$2,033

Payments by company (2024)

Takeda Pharmaceuticals U.S.A., Inc.
$385
ABBVIE INC.
$362
Axsome Therapeutics, Inc.
$355
Alkermes, Inc.
$277
Otsuka America Pharmaceutical, Inc.
$170
IDORSIA PHARMACEUTICALS US INC
$154
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$131
Tris Pharma Inc
$82
Lundbeck LLC
$58
Janssen Pharmaceuticals, Inc
$54
Neos Therapeutics, LP
$17
Noven Therapeutics, LLC
$16
Bausch Health US, LLC
$16
Top 3 companies account for 53.1% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$1,614
Takeda Pharmaceuticals U.S.A., Inc.
$923
Lundbeck LLC
$754
ABBVIE INC.
$724
Allergan Inc.
$712
Axsome Therapeutics, Inc.
$694
Alkermes, Inc.
$665
AbbVie Inc.
$605
ITI, Inc.
$603
Sunovion Pharmaceuticals Inc.
$561
IDORSIA PHARMACEUTICALS US INC
$520
Bausch Health US, LLC
$433
Janssen Pharmaceuticals, Inc
$386
Teva Pharmaceuticals USA, Inc.
$364
Neos Therapeutics, LP
$335
JAZZ PHARMACEUTICALS INC.
$314
Allergan, Inc.
$302
Tris Pharma Inc
$254
Eisai Inc.
$243
Supernus Pharmaceuticals, Inc.
$243
Ironshore Pharmaceuticals Inc.
$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$131
Otsuka Pharmaceutical Development & Commercialization, Inc.
$128
Avanir Pharmaceuticals, Inc.
$124
Neurocrine Biosciences, Inc.
$115
Alfasigma USA, Inc.
$113
Neuronetics, Inc.
$93
Corium, LLC
$89
ARBOR PHARMACEUTICALS, INC.
$72
Arbor Pharmaceuticals, Inc.
$62
Shire North American Group Inc
$52
Adlon Therapeutics L.P.
$52
Vanda Pharmaceuticals Inc.
$21
EISAI INC.
$20
Almatica Pharma LLC
$18
Merck Sharp & Dohme Corporation
$18
Noven Therapeutics, LLC
$16
Jazz Pharmaceuticals Inc.
$14
OWP Pharmaceuticals, Inc.
$11
Top 3 companies account for 26.2% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COTEMPLA XR-ODT · Dayvigo · Dyanavel XR · Evekeo · Evekeo ODT · GRALISE · HETLIOZ · Horizant · INGREZZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · Lamotrigine Starter Kit · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · QELBREE · QUVIVIQ · REXULTI · SPRAVATO · SUNOSI · TRINTELLIX · Trintellix · VIIBRYD · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL · XYWAV · Xelstrym
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in St Petersburg?
Compare psychiatrists in the St Petersburg area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
351
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH BAYFRONT HOSPITAL
1.8 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Beltran Durango is a psychiatry specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Beltran Durango receive payments from pharmaceutical companies?
Yes. Dr. Beltran Durango received a total of $12,561 from 39 companies across 529 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Beltran Durango) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in St Petersburg
Browse psychiatrists in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in FL
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in FL
Which FL psychiatrists receive the most from drug and device companies.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →